Found: 7
Select item for more details and to access through your institution.
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.25281
- By:
- Publication type:
- Article
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22186-0
- By:
- Publication type:
- Article
Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 1, p. 1, doi. 10.1002/adtp.202000124
- By:
- Publication type:
- Article
Melanoma: Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma (Adv. Therap. 8/2020).
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 8, p. 1, doi. 10.1002/adtp.202070017
- By:
- Publication type:
- Article
Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 8, p. 1, doi. 10.1002/adtp.202000028
- By:
- Publication type:
- Article
Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.
- Published in:
- FASEB Journal, 2018, v. 32, n. 11, p. 5835, doi. 10.1096/fj.201701568R
- By:
- Publication type:
- Article
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02283-9
- By:
- Publication type:
- Article